Vaccination Snapshots: COVID-19 and Beyond

Commentary
Slideshow

Click through a short slideshow review of the available COVID-19 vaccines for adults and children and of the long COVID symptoms to watch for in all your patients.

In the new Patient Care® Primary View video series titled "Vaccination Insights: Navigating COVID-19 and Beyond," Drs Tina Q Tan and Rodney E Rohde, PhD, MS, SM(ASCP)CM, discussed topics ranging from COVID-19 and other immunizations in pediatric populations to who may be at greatest risk for long COVID. They also reviewed the features that position mRNA vaccine technology to be revolutionary to health care of the future.

The short slide show below highlights the current Centers for Disease Control and Prevention recommendations for vaccination against COVID-19 that Tan and Rohde discuss in the video series.

Click here to watch the full "Vaccination Insights: Navigating COVID-19 and Beyond," video series.

Related Content
FDA Accepts Merck's BLA for Clesrovimab, an Investigational mAb Against RSV in Infants

FDA Accepts Merck's BLA for Clesrovimab, an Investigational mAb Against RSV in Infants

Grace Halsey
December 17th 2024
Article

Clesrovimab, if approved, would be the only immunization for both healthy and at risk infants using the same dose. FDA set A PDUFA date of June 2025.

Safety of Moderna’s mRNA RSV Vaccine for Infants Heads Dec 12 VRBPAC Meeting Agenda / image credit Naumov_2/stock.adobe.com

Safety of Moderna’s mRNA RSV Vaccine for Infants Heads Dec 12 VRBPAC Meeting Agenda

Grace Halsey
December 11th 2024
Article

Moderna paused clinical research on the pediatric shot indefinitely in September after reports in July of severe adverse reactions in infants aged 5 to 8 months.

HPV Vaccination Rates, Clinician Recommendations Lag at Public Health Care Facilities / image credit adolescents vaccinated : ©Serhii/stock.adobe.com

HPV Vaccination Rates, Clinician Recommendations Lag at Public Health Care Facilities

Grace Halsey
August 2nd 2024
Article

HPV series initiation and completion was lower among adolescents seen at public vs private care settings and so was clinician guidance on vaccination in a new study.

States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence / Image credit: ©Alessandro Grandini/AdobeStock

States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence

Sydney Jennings
July 9th 2024
Article

A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.

Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study

Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study

John Parkinson
May 2nd 2024
Article

In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).

GSK Announces FDA PDUFA Date for 5-in-1 Meningococcal Vaccine / image credit GSK vaccines: ©desertsands/stock.adobe.com

GSK Announces FDA PDUFA Date for 5-in-1 Meningococcal Vaccine Based on Acceptance of BLA

Grace Halsey
April 17th 2024
Article

The FDA expects to take action on the GSK BLA for its pentavalent MenB vaccine by February 14, 2025.

© 2024 MJH Life Sciences

All rights reserved.